Scheme published to fast-track access to crucial medicines
Big Pharma boss appointed to lead the new pathway Related items fromOnMedica Pharmaceutical industry regulation undermines NICE drugs appraisal work NICE fast-tracks approval of new skin cancer treatment UK spends 20% less on cancer treatment than rest of EU Pharma trade body rejects appeal for judicial review after High Court ruling The medicine price debate
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Cancer | Cancer & Oncology | Legislation | National Institute for Health and Clinical Excelle | Pharmaceuticals | Skin | Skin Cancer | UK Health